These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 23917322
1. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Zusman O, Avni T, Leibovici L, Adler A, Friberg L, Stergiopoulou T, Carmeli Y, Paul M. Antimicrob Agents Chemother; 2013 Oct; 57(10):5104-11. PubMed ID: 23917322 [Abstract] [Full Text] [Related]
2. Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. Scudeller L, Righi E, Chiamenti M, Bragantini D, Menchinelli G, Cattaneo P, Giske CG, Lodise T, Sanguinetti M, Piddock LJV, Franceschi F, Ellis S, Carrara E, Savoldi A, Tacconelli E. Int J Antimicrob Agents; 2021 May; 57(5):106344. PubMed ID: 33857539 [Abstract] [Full Text] [Related]
3. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis. Ni W, Shao X, Di X, Cui J, Wang R, Liu Y. Int J Antimicrob Agents; 2015 Jan; 45(1):8-18. PubMed ID: 25465524 [Abstract] [Full Text] [Related]
4. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H, Kus H, Arslan U, Tuncer I. Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [Abstract] [Full Text] [Related]
5. In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques. Soudeiha MAH, Dahdouh EA, Azar E, Sarkis DK, Daoud Z. Front Cell Infect Microbiol; 2017 Apr; 7():209. PubMed ID: 28596943 [Abstract] [Full Text] [Related]
6. Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria. Wang Y, Feng J, Yu J, Wen L, Chen L, An H, Xiao W, Zhang B, Feng H, Zhou M, Jiang Z. Ann Clin Microbiol Antimicrob; 2024 Jul 04; 23(1):60. PubMed ID: 38965559 [Abstract] [Full Text] [Related]
12. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC, Choi JA, Jang SJ, Jeong SH, Kim CM, Choi IS, Kang SH, Park G, Moon DS. Ann Lab Med; 2016 Mar 04; 36(2):124-30. PubMed ID: 26709259 [Abstract] [Full Text] [Related]
13. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii. Bian X, Liu X, Feng M, Bergen PJ, Li J, Chen Y, Zheng H, Song S, Zhang J. Int J Antimicrob Agents; 2021 Feb 04; 57(2):106271. PubMed ID: 33352235 [Abstract] [Full Text] [Related]
15. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance. Laishram S, Anandan S, Devi BY, Elakkiya M, Priyanka B, Bhuvaneshwari T, Peter JV, Subramani K, Balaji V. J Chemother; 2016 Aug 04; 28(4):297-303. PubMed ID: 27461479 [Abstract] [Full Text] [Related]
16. In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae. Clock SA, Tabibi S, Alba L, Kubin CJ, Whittier S, Saiman L. Diagn Microbiol Infect Dis; 2013 Jul 04; 76(3):343-6. PubMed ID: 23601454 [Abstract] [Full Text] [Related]
18. Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis. Jiang Z, He X, Li J. Infect Drug Resist; 2018 Jul 04; 11():1083-1095. PubMed ID: 30122965 [Abstract] [Full Text] [Related]